Cinqair

Active Ingredient(s): Reslizumab
FDA Approved: * March 23, 2016
Pharm Company: * TEVA RESPIRATORY LLC
Category: Asthma

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Cinqair Overview

Reslizumab is a humanized monoclonal antibody against human interleukin-5 (IL-5).[1] Reslizumab binds specifically to IL-5, a key cytokine responsible for the differentiation, maturation, recruitment and activation of human eosinophils. By binding to human IL-5, it blocks its biological function; consequently survival and activity of eosinophils are reduced. The benefits with reslizumab are its ability to reduce the exacerbation rate and improve lung function and asthma-relate...

Read more Cinqair Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Reslizumab

Recent Cinqair Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Reslizumab
  • Injection: 100mg/10ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cinqair: (1 result)

Sorted by National Drug Code
  • 59310-610 Cinqair 10 mg/ml Intravenous Injection, Solution, Concentrate by Teva Respiratory, LLC

Other drugs which contain Reslizumab or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA